The Skills Gap in Peptide Manufacturing and How to Close It

There are not enough qualified peptide manufacturing workers to meet current demand. This is not a future problem or a theoretical concern. It is happening right now, and it is slowing down drug development programs at companies across the country.

The peptide manufacturing workforce has always been small, but the recent explosion in GLP-1 and oncology peptide demand has made the gap more visible and more urgent. Companies that do not act now will find themselves competing for an even smaller pool of qualified workers as demand continues to grow.

What Is Driving the Skills Gap

Rapid Market Growth Outpacing Workforce Supply

The peptide therapeutics market has grown faster than universities and training programs could keep up with. A decade ago, peptide manufacturing was a niche specialty. Today it sits at the center of some of the most commercially important drug programs in the industry.

GLP-1 drugs like semaglutide have driven enormous investment in peptide manufacturing capacity. New plants are being built, existing facilities are scaling up, and every program needs trained operators, quality scientists, and process engineers who understand peptide-specific manufacturing requirements.

The global contract peptide manufacturing market is expected to grow at a compound annual growth rate of over 9% through 2030. That pace of growth far exceeds the rate at which universities are producing graduates with relevant training.

Limited Formal Training Programs

Unlike pharmaceutical manufacturing, which has broad support from community colleges and technical schools, peptide manufacturing has very few dedicated educational programs. Most peptide manufacturers have been trained on the job, through apprenticeship-style arrangements at companies with experienced teams.

This creates a bottleneck. The supply of new talent is constrained by the supply of experienced mentors who have time to train them. When experienced workers retire or change companies, they take institutional knowledge with them that is difficult to replace quickly.

High Competition for the Same Small Pool

Every growing peptide company is looking for the same people. Synthetic chemists with SPPS experience, quality assurance professionals who understand GMP peptide requirements, and process engineers who have scaled peptide synthesis from grams to kilograms are all in extremely high demand.

This competition drives up salaries, which is good for workers but creates challenges for early-stage companies with limited budgets. It also means that even well-resourced companies sometimes cannot fill critical positions for months.

John Carbonell, Senior Director of Technical Operations, Bachem AG, BioPharma Manufacturing Quarterly: "The biologics and peptide sectors are facing a compounding talent crisis, where the demand for GMP-trained professionals is outpacing the supply from traditional academic pipelines by a significant margin"

The Specific Skills That Are Hardest to Find

GMP-Ready Peptide Operators

Operators who can run automated peptide synthesizers, manage resin loading, and execute processes in a GMP environment are particularly scarce. The GMP layer adds regulatory knowledge requirements that most researchers do not have.

Many candidates have research experience but have never worked in a facility with batch records, deviation reporting, or change control procedures. Bridging that gap requires time and deliberate training.

Analytical Scientists with Peptide Specialization

Analytical method development for peptides requires specific expertise. HPLC method development for complex peptide mixtures, peptide mapping, and characterization of modifications like cyclization or PEGylation all require skills that are not widely taught in standard analytical chemistry programs.

Finding candidates who have both the analytical science foundation and the peptide-specific experience is genuinely difficult. Many companies end up hiring strong analytical scientists and investing in specialized training.

Process Development and Scale-Up Engineers

Taking a peptide synthesis process from research scale to manufacturing scale is a distinct discipline. It requires understanding reactor engineering, solvent management, purification capacity, and process analytical technology in the context of peptide chemistry.

Few academic programs combine all of these elements. Most process development engineers in this space have assembled their skills through a combination of academic training and hands-on industry experience across multiple roles.

There are fewer than a dozen accredited university programs in the United States that include dedicated peptide synthesis coursework as part of a pharmaceutical sciences or biotech degree.

How Companies Are Closing the Gap

Building Internal Training Programs

The most successful peptide manufacturers are not waiting for the talent market to solve this problem. They are building structured internal training programs that take talented candidates from adjacent fields and develop them into capable peptide manufacturing professionals.

This approach requires investment. You need dedicated trainers, documented training materials, and a structured curriculum. But the return on that investment is significant. Companies that build strong training programs tend to have lower turnover, stronger team loyalty, and less dependence on an increasingly expensive external talent market.

Start by documenting your own processes thoroughly. Training programs cannot exist without clear standard operating procedures (SOPs), work instructions, and knowledge repositories. The documentation work itself often surfaces inefficiencies in current processes.

Partnering with Universities and Community Colleges

Some forward-thinking peptide companies have begun partnering directly with nearby universities and community colleges to shape curriculum and create a local talent pipeline. This takes time to develop but can be a long-term competitive advantage.

Partnerships can take different forms. You might offer internships that give students real manufacturing experience. You might sponsor a course on GMP manufacturing practices at a local school. Some companies have funded laboratory equipment for academic programs in exchange for early access to graduates.

If you are a larger company, consider reaching out to chemistry departments at local universities to discuss co-op programs. These give students paid work experience while giving you an early look at emerging talent.

Expanding the Talent Pool Through Inclusion

One effective way to address a skills gap is to expand the definition of who you are willing to hire and train. Many peptide companies reflexively require a chemistry degree for roles that could be filled effectively by candidates from biology, pharmacy, or chemical engineering backgrounds with some targeted training.

Broadening your hiring criteria does not mean lowering your standards. It means recognizing that many relevant skills transfer across scientific disciplines and that on-the-job training can fill specific gaps. This approach also tends to increase workforce diversity, which has well-documented benefits for team performance and innovation.

Using Contract and Staffing Talent Strategically

For immediate skill gaps that cannot wait for a training program to develop, contract staffing can fill the gap. Experienced contract workers with GMP peptide manufacturing experience can contribute immediately while you build your longer-term workforce.

This approach is especially useful for project-specific needs. If you need GMP-level analytical method development for a specific program, a contract scientist with that specialty can complete the work without committing to a full-time hire.

See our guide on staffing agency vs. direct hire for peptide biotech for a framework to decide when each approach makes the most sense for your organization.

Retaining the Talent You Have

Every experienced peptide manufacturing professional who leaves your company represents a significant loss. They take their knowledge, their skills, and potentially their network of future colleagues with them.

Retention is not just about salary. It requires clear career paths, regular recognition, investment in professional development, and a work environment where people feel valued. Conduct stay interviews with your best performers to understand what keeps them engaged and what might lead them to leave.

Pay attention to total compensation, not just base salary. Equity, flexible schedules, conference access, and tuition reimbursement all contribute to retention in ways that matter to working scientists.

Pair every new hire with a senior operator for at least the first 90 days on the floor, and document what that mentor teaches so institutional knowledge survives turnover.

Policy and Industry-Level Solutions

Individual companies cannot solve a systemic workforce problem alone. The peptide manufacturing industry needs collective action to build the workforce pipeline at scale.

Industry groups like the Bio Industry Organization and the Society for Biological Engineering play a role here. Companies can advocate for increased federal investment in biomanufacturing workforce development, support initiatives like the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), and participate in regional workforce coalitions.

According to the National Institutes of Health workforce development pages, federal investment in life science training programs has increased in recent years, but much of the funding focuses on academic research rather than manufacturing and process development. Advocating for a broader view of workforce needs is part of how the industry can shape a better long-term outcome.

Measuring Progress on the Skills Gap

If you are taking active steps to close your company's skills gap, you need a way to measure progress. Track metrics like average time to fill manufacturing roles, the percentage of roles filled by internal promotions, and retention rates for key manufacturing positions.

Also track leading indicators: the number of people currently in your training pipeline, the progress of university partnerships, and the depth of your talent database. These upstream metrics will predict future hiring success before the results show up in your fill rates.

For help thinking through workforce planning in a growing peptide company, see our guide on workforce planning for growing peptide companies.

Companies that build internal training pipelines now will have a decisive hiring and production advantage as GLP-1 and oncology peptide demand continues to outpace the available workforce.

FAQs

What is the skills gap in peptide manufacturing? The skills gap refers to the difference between the skills that peptide manufacturing companies need and the skills that available workers currently have. In peptide manufacturing, the gap is most pronounced in GMP operations, analytical method development, and process scale-up.

How long does it take to train a peptide manufacturing operator? A motivated candidate with a chemistry background can become a competent GMP peptide operator in 6 to 12 months with structured training. More complex roles like process development or QA management typically require 2 to 3 years to develop fully.

Why is peptide manufacturing harder to staff than general pharmaceutical manufacturing? Peptide chemistry is a specialized discipline with its own techniques, equipment, and analytical approaches. Most general pharmaceutical manufacturing workers do not have direct experience with SPPS, peptide purification, or peptide-specific regulatory requirements, which narrows the qualified candidate pool.

What can small biotech startups do if they cannot afford large training programs? Start with documentation. Write clear SOPs for every process. Then prioritize hiring one experienced scientist who can mentor others. Even a small mentorship structure can transfer knowledge effectively. Supplement with targeted contract staffing for specialized needs.

Is outsourcing peptide manufacturing a good way to avoid the skills gap? Outsourcing to a CDMO can be a good short-term solution, but it creates its own dependencies. Companies that outsource all manufacturing may find it harder to build internal expertise and may face challenges as their programs advance and internal CMC knowledge becomes critical.